herenciageneticayenfermedad: Hematology | Medical News | Medical Articles

martes, 28 de mayo de 2019

Hematology | Medical News | Medical Articles | Hematology |

	May 28, 2019
	Hematology
	The latest hematology news from News Medical

Reliable Point of Care Lactate Analysis in Cattle

Research has indicated that it is extremely useful to measure lactate concentrations in cattle. The new methods available to veterinarians and farmers in order to achieve reliable and quick results without leaving the animal’s side are discussed in this article.

Read Full Article Here

			New blood-cell analysis device helps better understand causes and mechanics of rare anemia An EU-funded project has developed a blood-cell analysis device that helps doctors and scientists better understand the causes and mechanics of rare forms of anemia - potentially speeding up the development of new treatments adjusted to the needs of patients with these diseases.

			Scientists propose new way of delivering anti-thrombosis drugs to damaged blood vessels Scientists from Tomsk Polytechnic University with colleagues from Great Britain Germany, China, and Switzerland have proposed a new way of delivering anti-thrombosis drugs to the damaged areas of the blood vessels.

	Hereditary Spherocytosis Related Disorders Hereditary spherocytosis (HS) is an inherited condition that affects the red blood cells. The cells are damaged as they pass through the spleen and do not survive as long as normal blood cells. Typical early-stage symptoms include anemia, but patients will often develop other conditions as a result of hereditary spherocytosis.

	WVU researcher studies stubborn blood disease that strikes children Treating a stubborn blood disease that strikes children may come down to tweaking energy production in stem cells, suggests research out of West Virginia University.

	What is Myelofibrosis? Myelofibrosis is a rare condition affecting the bone marrow. Following initial overproduction of blood cells, scar tissue builds up inside the bone marrow. Although it can affect people at any age, it most commonly develops in people over the age of 50.

	What is Factor V Leiden? Factor V Leiden is not a disease, but a genetic mutation that results in thrombophilia, a blood clotting condition that increases a person’s risk of developing abnormal blood clots in their blood vessels.